Tasso, Inc. is a U.S.-based company founded in 2012, specializing in the manufacturing of medical devices and equipment within the biotech and pharmaceuticals sectors. With an employee count ranging from 51 to 200, Tasso focuses on innovative solutions for healthcare, particularly in the area of blood testing. Their recent research, as detailed in a 2024 patient survey white paper, highlights the evolving challenges in diagnostic healthcare testing and the importance of patient preferences. The survey, which engaged over 600 adults, reveals that patients increasingly seek convenient, home-based blood testing options, especially in the wake of the COVID-19 pandemic. Key findings indicate that many patients are reluctant to travel for blood tests, often delaying necessary procedures due to inconvenience and accessibility issues. Tasso's insights suggest that enhancing remote blood testing methods could significantly improve patient compliance and engagement in healthcare. The company is positioned to address these needs through its innovative approaches to diagnostic testing.